Rapid screening of brain-penetrable antioxidants from natural products by blood-brain barrier specific permeability assay combined with DPPH recognition

2018 ◽  
Vol 151 ◽  
pp. 42-48 ◽  
Author(s):  
Junfeng Zhu ◽  
Xiaojiao Yi ◽  
Jinghui Zhang ◽  
Shuqing Chen ◽  
Yongjiang Wu
2021 ◽  
Vol 22 (7) ◽  
pp. 3356
Author(s):  
Manon Leclerc ◽  
Stéphanie Dudonné ◽  
Frédéric Calon

The scope of evidence on the neuroprotective impact of natural products has been greatly extended in recent years. However, a key question that remains to be answered is whether natural products act directly on targets located in the central nervous system (CNS), or whether they act indirectly through other mechanisms in the periphery. While molecules utilized for brain diseases are typically bestowed with a capacity to cross the blood–brain barrier, it has been recently uncovered that peripheral metabolism impacts brain functions, including cognition. The gut–microbiota–brain axis is receiving increasing attention as another indirect pathway for orally administered compounds to act on the CNS. In this review, we will briefly explore these possibilities focusing on two classes of natural products: omega-3 polyunsaturated fatty acids (n-3 PUFAs) from marine sources and polyphenols from plants. The former will be used as an example of a natural product with relatively high brain bioavailability but with tightly regulated transport and metabolism, and the latter as an example of natural compounds with low brain bioavailability, yet with a growing amount of preclinical and clinical evidence of efficacy. In conclusion, it is proposed that bioavailability data should be sought early in the development of natural products to help identifying relevant mechanisms and potential impact on prevalent CNS disorders, such as Alzheimer’s disease.


2011 ◽  
Vol 13 (12) ◽  
pp. 1087-1097 ◽  
Author(s):  
Zhi-Hong Yang ◽  
Xiao Sun ◽  
Chao Mei ◽  
Xiao-Bo Sun ◽  
Xiao-Dong Liu ◽  
...  

2003 ◽  
Vol 38 (3) ◽  
pp. 223-232 ◽  
Author(s):  
Li Di ◽  
Edward H Kerns ◽  
Kristi Fan ◽  
Oliver J McConnell ◽  
Guy T Carter

2005 ◽  
Vol 11 (1) ◽  
pp. 13-20 ◽  
Author(s):  
Chi Ho Yoon ◽  
Soo Jin Kim ◽  
Beom Soo Shin ◽  
Kang Choon Lee ◽  
Sun Dong Yoo

The chromatographic capacity factors (kIAM) of 23 structurally diverse drugs were measured by the immobilized artificial membrane (kIAM) phosphatidylcholine chromatography for the prediction of blood-brain barrier (BBB) penetration. The kIAM was determined using themobile phase consisting of acetonitrile:DPBS (20:80 v/v) and corrected for the molar volume of the solutes (kIAM/MWn). The correlation between kIAM/MWn and CNS penetration was highest when measured at pH 5.5 with the power function of n = 4. This in vitro predictionmethod was validated with 7 newly synthesized PDE-4 inhibitors. The relationship between in vivo plasma-to-brain concentration ratios and in vitro CNS penetration was excellent ( r= 0.959). The developed in vitro prediction method may be used as a rapid screening tool for BBB penetration of drugs with passive transport mechanism, with high success, low cost, and reproducibility.


2012 ◽  
Vol 19 (12) ◽  
pp. 1830-1845 ◽  
Author(s):  
A. Kam ◽  
K. M. Li ◽  
V. Razmovski-Naumovski ◽  
S. Nammi ◽  
K. Chan ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document